GRP and medullary thyroid gland carcinoma: Recently, ProGRP measurement was tested in 212 patients with 235 thyroid nodules, classified into chronic thyroiditis, nodular goiter, papillary thyroid carcinoma, thyroid follicular neoplasm, follicular thyroid carcinoma, and MTC.